Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/24/2025

Anemia Management Guidelines

Diagnostic Evaluation

  • The American Society of Anesthesiologists recommends assessing the type of anemia based on MCV values: microcytic (<80 fL), normocytic (80-100 fL), or macrocytic (>100 fL) 3
  • For normocytic anemia, evaluate renal function, inflammatory markers, thyroid function, and vitamin B12 and folate levels 3
  • Check reticulocyte count to determine if anemia is regenerative (>10×10^9/L) or non-regenerative 3

Treatment Algorithm

  • The American College of Oncology recommends identifying and treating the underlying cause of anemia for mild to moderate anemia (Hb 8-10 g/dL) 1, 2
  • For iron deficiency, administer supplemental iron therapy, and consider intravenous iron in cancer patients with absolute or functional iron deficiency 4
  • For severe anemia (Hb <7-8 g/dL) or symptomatic patients, consider RBC transfusion using a restrictive strategy (Hb threshold <7 g/dL) 1, 2
  • Transfuse the minimum number of RBC units required to relieve symptoms or return to a safe Hb range 2

Special Considerations

  • Patient blood management focuses on three pillars: optimizing patient's own red cell mass 1, minimizing blood loss and bleeding 1, and evaluating physiological tolerance of anemia 2
  • For patients with non-myeloid malignancies receiving chemotherapy, consider erythropoiesis-stimulating agents (ESAs) if Hb <10 g/dL 1, 4
  • For symptomatic anemia in MDS patients, consider ESA therapy, and monitor iron, B12/folate status and maintain target levels 1, 4